By administering tamoxifen, these TGFβ-responding tumor cells could then be exclusively marked with YFP and lineage-traced, verifying their existence as bona fide cancer stem cells (CSCs), which first appeared at the benign, papilloma state and then expanded and contributed to cSCC progression (Yuan et al. 2022). Here, TGFB1 is linked to neoplasm.